Login / Signup

Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers.

Laksshman SundaramArvind KumarMatthew ZatzmanAdriana SalcedoNeal G RavindraShadi ShamsBrian H LouieS Tansu BagdatliMatthew A MyersShahab SarmashghiHyo Young ChoiWon-Young ChoiKathryn E YostYanding ZhaoJeffrey M GranjaToshinori HinoueDavid Neil HayesAndrew D CherniakIna FelauHani ChoudhryJean Claude ZenklusenKyle Kai-How FarhAndrew W McPhersonChristina CurtisPeter W Lairdnull nullM Ryan CorcesHoward Y ChangWilliam J GreenleafJohn A DemchokLiming YangRoy TarnuzzerSamantha J Caesar-JohnsonZhining WangAshley S DoaneEkta KhuranaMauro A A CastroAlexander J LazarBradley M BroomJohn N WeinsteinRehan AkbaniShwetha V KumarBenjamin J RaphaelChristopher K WongJoshua M StuartRojin SafaviChristopher C BenzBenjamin K JohnsonCindy KyiHui Shen
Published in: Science (New York, N.Y.) (2024)
To identify cancer-associated gene regulatory changes, we generated single-cell chromatin accessibility landscapes across eight tumor types as part of The Cancer Genome Atlas. Tumor chromatin accessibility is strongly influenced by copy number alterations that can be used to identify subclones, yet underlying cis-regulatory landscapes retain cancer type-specific features. Using organ-matched healthy tissues, we identified the "nearest healthy" cell types in diverse cancers, demonstrating that the chromatin signature of basal-like-subtype breast cancer is most similar to secretory-type luminal epithelial cells. Neural network models trained to learn regulatory programs in cancer revealed enrichment of model-prioritized somatic noncoding mutations near cancer-associated genes, suggesting that dispersed, nonrecurrent, noncoding mutations in cancer are functional. Overall, these data and interpretable gene regulatory models for cancer and healthy tissue provide a framework for understanding cancer-specific gene regulation.
Keyphrases